Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools

Aztreonam-avibactam synergy, a validation and comparison of diagnostic tools

IntroductionAntimicrobial resistance is a growing problem that necessitates the development of new therapeutic options. Cefiderocol and aztreonam (AT) are often the last active β-lactams for treating metallo-β-lactamases (MBL)-producing Gram-negative bacilli. In these difficult-to-treat bacterial st...

Full description

Bibliographic Details
Main Authors: Gil Verschelden, Maxim Noeparast, Anke Stoefs, Eveline Van Honacker, Kristof Vandoorslaer, Laura Vandervore, Margo Olbrecht, Kathleen Van Damme, Thomas Demuyser, Denis Piérard, Ingrid Wybo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Microbiology
Subjects:
aztreonam
avibactam
ceftazidime/avibactam
Enterobacterales
P. aeruginosa
S. maltophilia
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2023.1322180/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2023.1322180/full

Similar Items